Multicenter nonrandomized trial of ramosetron versus palonosetron in controlling chemotherapy-induced nausea and vomiting for colorectal cancer

PURPOSE: Chemotherapy-induced nausea and vomiting (CINV) have a negative impact on patients' quality of life and frequently pointed to as a major factor for treatment abandonment. Serotonin (5-HT(3)) receptor antagonist is considered as key treatment for CINV. Ramosetron and palonosetron are re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin Soo, Kim, Ji Yeon, Lee, Sang-Jeon, Park, Dong Kook, Namgung, Hwan, Kim, Chang Nam, Choi, Won Jun, Baek, Moo Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091445/
https://www.ncbi.nlm.nih.gov/pubmed/25025021
http://dx.doi.org/10.4174/astr.2014.87.1.9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091445/
https://www.ncbi.nlm.nih.gov/pubmed/25025021
http://dx.doi.org/10.4174/astr.2014.87.1.9

Ejemplares similares